Literature DB >> 15378222

Bridging the gap between therapeutic research results and physician prescribing decisions: knowledge transfer, a prerequisite to knowledge translation.

Jean-Pierre Boissel1, Emmanuel Amsallem, Michel Cucherat, Patrice Nony, Margaret C Haugh.   

Abstract

BACKGROUND: A wide gap continues to exist between available therapeutic research results and physician's prescribing. Numerous explanations account for this gap, but one central reason is the difficulty in transferring comprehensive research information to practicing clinicians. This problem arises from information overload and the growing complexity of research findings. We propose a multistep process that can be used to develop systems to bridge this information/prescription gap. The steps include: comprehensively collecting and summarizing clinical trial reports, scoring and ranking these according to their level of evidence, exploring and synthesizing the data using meta-analyses, summarizing these results, representing them in an easily understandable form, and transmitting the overview findings to prescribers at the time they need them. DISCUSSION: This ambitious endeavor is needed to ensure that prescribers have access to pertinent research results for use in their prescription decisions. We demonstrate in this article that there are no theoretical or technical obstacles to make the proposed system workable.

Mesh:

Year:  2004        PMID: 15378222     DOI: 10.1007/s00228-004-0816-2

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  38 in total

1.  Evidence should be accessible as well as relevant.

Authors:  M Falshaw; Y H Carter; R W Gray
Journal:  BMJ       Date:  2000-09-02

2.  Getting evidence to prescribers and patients or how to make EBM a reality.

Authors:  Jean-Pierre Boissel; Michel Cucherat; Emmanuel Amsallem; Patrice Nony; Malik Fardeheb; Wilmondes Manzi; Margaret C Haugh
Journal:  Stud Health Technol Inform       Date:  2003

3.  Getting to grips with Archie Cochrane's agenda.

Authors:  I Chalmers; K Dickersin; T C Chalmers
Journal:  BMJ       Date:  1992-10-03

Review 4.  Level of evidence and therapeutic evaluation: need for more thoughts.

Authors:  Nadine Bossard; François-Henri Boissel; Jean-Pierre Boissel
Journal:  Fundam Clin Pharmacol       Date:  2004-06       Impact factor: 2.748

5.  Absolutely relative: how research results are summarized can affect treatment decisions.

Authors:  L Forrow; W C Taylor; R M Arnold
Journal:  Am J Med       Date:  1992-02       Impact factor: 4.965

6.  Prescription intentions in relation to therapeutic information: a study of 117 French general practitioners.

Authors:  P Cialdella; G Figon; M C Haugh; J P Boissel
Journal:  Soc Sci Med       Date:  1991       Impact factor: 4.634

7.  An effect model for the assessment of drug benefit: example of antiarrhythmic drugs in postmyocardial infarction patients.

Authors:  J P Boissel; J P Collet; M Lievre; P Girard
Journal:  J Cardiovasc Pharmacol       Date:  1993-09       Impact factor: 3.105

8.  The impact of controlled trials on the practice of medicine.

Authors:  T C Chalmers
Journal:  Mt Sinai J Med       Date:  1974 Nov-Dec

9.  Information needs in office practice: are they being met?

Authors:  D G Covell; G C Uman; P R Manning
Journal:  Ann Intern Med       Date:  1985-10       Impact factor: 25.391

10.  Analysis of questions asked by family doctors regarding patient care.

Authors:  J W Ely; J A Osheroff; M H Ebell; G R Bergus; B T Levy; M L Chambliss; E R Evans
Journal:  BMJ       Date:  1999-08-07
View more
  10 in total

1.  A practical method for transforming free-text eligibility criteria into computable criteria.

Authors:  Samson W Tu; Mor Peleg; Simona Carini; Michael Bobak; Jessica Ross; Daniel Rubin; Ida Sim
Journal:  J Biomed Inform       Date:  2010-09-17       Impact factor: 6.317

Review 2.  Facilitating the implementation of empirically valid interventions in psychosocial oncology and supportive care.

Authors:  Thomas F Hack; Linda Carlson; Lorna Butler; Lesley F Degner; Fabijana Jakulj; Tom Pickles; J Dean Ruether; Lorna Weir
Journal:  Support Care Cancer       Date:  2011-04-15       Impact factor: 3.603

3.  Clinical pharmacology in everyday clinical care.

Authors:  Petra A Thürmann
Journal:  Eur J Clin Pharmacol       Date:  2013-05-03       Impact factor: 2.953

4.  The contribution of conceptual frameworks to knowledge translation interventions in physical therapy.

Authors:  Anne Hudon; Mathieu-Joël Gervais; Matthew Hunt
Journal:  Phys Ther       Date:  2014-07-24

5.  Study protocol: addressing evidence and context to facilitate transfer and uptake of consultation recording use in oncology: a knowledge translation implementation study.

Authors:  Thomas F Hack; J Dean Ruether; Lorna M Weir; Debjani Grenier; Lesley F Degner
Journal:  Implement Sci       Date:  2011-03-14       Impact factor: 7.327

6.  Problem-oriented drug information: physicians' expectations and impact on clinical practice.

Authors:  U Hedegaard; P Damkier
Journal:  Eur J Clin Pharmacol       Date:  2009-01-10       Impact factor: 2.953

7.  "Integrated knowledge translation" for globally oriented public health practitioners and scientists: Framing together a sustainable transfrontier knowledge translation vision.

Authors:  Véronique Lapaige
Journal:  J Multidiscip Healthc       Date:  2010-06-01

Review 8.  Bridging Systems Medicine and Patient Needs.

Authors:  J-P Boissel; C Auffray; D Noble; L Hood; F-H Boissel
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2015-03-27

9.  Ethnodrama: An Innovative Knowledge Translation Tool in the Management of Lymphedema.

Authors:  Shahid Ahmed; Elizabeth Quinlan; Linda McMullen; Roanne Thomas; Pam Fichtner; Janice Block
Journal:  J Cancer       Date:  2015-07-16       Impact factor: 4.207

Review 10.  Systems Biology Approaches for Therapeutics Development Against COVID-19.

Authors:  Shweta Jaiswal; Mohit Kumar; Yogendra Singh; Pratyoosh Shukla
Journal:  Front Cell Infect Microbiol       Date:  2020-10-28       Impact factor: 5.293

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.